Universal tranexamic acid therapy to minimize transfusion for major joint arthroplasty: a retrospective analysis of protocol implementation

Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie
James E BakerGregory M T Hare

Abstract

Tranexamic acid (TXA) therapy can reduce red blood cell (RBC) transfusion; however, this therapy remains underutilized in many surgical patient populations. We assessed whether implementation of a protocol to facilitate universal administration of TXA in patients undergoing total hip or knee arthroplasty would reduce the incidence of RBC transfusion without increasing adverse clinical outcomes. We implemented a quality of care policy to provide universal administration of intravenous TXA at a dose of 20 mg·kg(-1) iv to all eligible patients undergoing total hip or knee arthroplasty from October 21, 2013 to April 30, 2014. We compared data from an equal number of patients before and after protocol implementation (n = 422 per group). The primary outcome was RBC transfusion with secondary outcomes including postoperative hemoglobin concentration (Hb) and length of hospital stay. Adverse events were identified from the electronic medical records. Data were analyzed by a Chi square test and adjusted logistic and linear regression analysis. Implementation of the protocol resulted in an increase in TXA utilization from 45.8% to 95.3% [change 49.5%; 95% confidence interval (CI), 44.1 to 54.5; P < 0.001]. This change was associated with...Continue Reading

References

Jul 31, 2001·The Journal of Bone and Joint Surgery. British Volume·N TanakaS Ishii
Feb 14, 2002·The Journal of Surgical Research·James R DunneLena M Napolitano
Nov 23, 2005·Anesthesia and Analgesia·Lawrence T GoodnoughRichard Spence
Oct 27, 2006·Anesthesiology·Paul ZuffereySerge Molliex
Jan 4, 2008·Circulation·Keyvan KarkoutiUNKNOWN Reducing Bleeding in Cardiac Surgery (RBC) Investigators
May 16, 2008·The New England Journal of Medicine·Dean A FergussonUNKNOWN BART Investigators
Nov 6, 2009·Interactive Cardiovascular and Thoracic Surgery·Yolanda CarrascalEnrique Fulquet
Jan 12, 2010·Clinical Orthopaedics and Related Research·Fiona E RalleyDouglas D R Naudie
Jul 30, 2010·The Annals of Thoracic Surgery·David M MoskowitzM Arisan Ergin
Oct 14, 2010·JAMA : the Journal of the American Medical Association·Aryeh S Shander, Lawrence T Goodnough
Nov 5, 2010·The Journal of Bone and Joint Surgery. American Volume·Jean WongFrances Chung
Oct 18, 2011·Acta Orthopaedica·Jamie S McConnellAndrew W G Kinninmonth
Dec 22, 2011·British Journal of Anaesthesia·A ShanderG M T Hare
Apr 11, 2012·Anesthesiology·Lawrence Tim Goodnough, Aryeh Shander
May 23, 2012·BMJ : British Medical Journal·Katharine KerIan Roberts
Nov 21, 2012·BMJ : British Medical Journal·Russell L Gruen, Michael C Reade
Jan 29, 2013·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Gregory M T HareC David Mazer
Feb 5, 2013·BMJ Case Reports·Amr SalamVincent Mak

❮ Previous
Next ❯

Citations

Aug 27, 2015·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Fiona E Ralley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.